Amr Ehab El-Qushayri’s Post

**New Publication** Our MEL protocol is now published in BMJ Paediatrics Open. Those working on multi-country, interdisciplinary research project involving very large data set understands the value of having a strong MEL framework and procedures. However, in publishing research articles, the supporting MEL method is often not given the prominence it deserves. We are changing perspectives around that. Read more here: https://lnkd.in/eJQNTps5

𝐑𝐞𝐬𝐞𝐚𝐫𝐜𝐡 𝐏𝐚𝐩𝐞𝐫𝐬 𝐄𝐱𝐩𝐥𝐚𝐢𝐧𝐞𝐝 – 𝐟𝐢𝐫𝐬𝐭 𝐩𝐚𝐩𝐞𝐫 𝐭𝐫𝐚𝐧𝐬𝐥𝐚𝐭𝐞𝐝! “𝐄𝐱𝐩𝐞𝐫𝐢𝐞𝐧𝐜𝐞𝐬 𝐨𝐟 𝐜𝐥𝐢𝐧𝐢𝐜𝐚𝐥 𝐭𝐫𝐢𝐚𝐥𝐬 𝐢𝐧 𝐡𝐨𝐦𝐞𝐬 𝐚𝐧𝐝 𝐥𝐨𝐜𝐚𝐥 𝐬𝐞𝐭𝐭𝐢𝐧𝐠𝐬 𝐨𝐮𝐭𝐬𝐢𝐝𝐞 𝐨𝐟 𝐜𝐥𝐢𝐧𝐢𝐜𝐬 – 𝐚 𝐫𝐞𝐬𝐞𝐚𝐫𝐜𝐡 𝐩𝐫𝐨𝐣𝐞𝐜𝐭 𝐮𝐬𝐢𝐧𝐠 𝐢𝐧𝐭𝐞𝐫𝐯𝐢𝐞𝐰𝐬” WP CODE has recently formed a working group to translate technical/scientific documents into plain language for the general public including patients. It’s intended for those interested in learning more about decentralised clinical trials (DCT) in a more accessible and easily digestible format. The aim of this group is to foster accessibility of the Trials@Home materials, to increase awareness and educational opportunities surrounding DCTs. The group has now finished the translation of the first paper “Learning from remote decentralised clinical trial experiences: A qualitative analysis of interviews with trial personnel, patient representatives and other stakeholders” Download the translation here -> https://bit.ly/3Xz5vdz

Heading to SupplySide West 2024? PeopleScience is sponsoring a crucial conversation about the future of clinical trials. Come find us - we’d love to help you transform your brand with science-backed claims.  "The Future of Clinical Trial Design: Inclusivity as Axiom" - a learning power-hour focused on building more representative, effective research. 📅 October 31, 2024 ⏰ 9:00 AM PT 📍 Islander Ballroom E Industry experts will explore: 🔬 Designing trials that truly represent your target population 🌎 Solving unique challenges in population-specific research 🤝 Best practices for inclusive trial design Hear from: * Douglas Kalman PhD RD, Clinical Associate Professor, Nova Southeastern University * Barry Skillington, Chief Commercial Officer, Atlantia Clinical Trials * David Foreman, President, Herbal Pharmacist * Erin D Lewis, PhD, Scientific Director, KGK Science Inc. * Susan Hewlings, VP of Research Affairs, Radicle Science * Duffy Hayes, Managing Editor, SupplySide Journals Can’t join the session? Our team will be at the conference and ready to discuss how to make your clinical research more inclusive and impactful. Let's connect! Drop a comment if you'll be there, or reach out directly to schedule a time to chat! #ClinicalTrials #ResearchInnovation #SupplySideWest #InclusiveResearch #PeopleScience

If you are at #SupplySideWest this week, come join our October 31st morning session discussing "inclusivity" as an aspect of study design. Thematically, we will discuss what does "inclusivity" mean and how does it fit into research that is executed on dietary supplements. Thank you to People Science for having me as one of the presenters/panelists. If your company has a research need or questions about study design or even how or where to execute a clinical, please let's meet after the session or contact us at Substantiation Sciences for answers, guidance and a little "TLC". #dietaryingreidents #dietarysupplements #research #clinicaltrials #clinicalstudy #health #substantiation #evidence #data #regulatory #science #art #consultancy #info #strategicguidance #intellectualproperty #IP #valuation #GCP #diversity #inclusivity #outcomesdata #SFC

𝐑𝐞𝐬𝐞𝐚𝐫𝐜𝐡 𝐏𝐚𝐩𝐞𝐫𝐬 𝐄𝐱𝐩𝐥𝐚𝐢𝐧𝐞𝐝 – 𝐟𝐢𝐫𝐬𝐭 𝐩𝐚𝐩𝐞𝐫 𝐭𝐫𝐚𝐧𝐬𝐥𝐚𝐭𝐞𝐝! “𝐄𝐱𝐩𝐞𝐫𝐢𝐞𝐧𝐜𝐞𝐬 𝐨𝐟 𝐜𝐥𝐢𝐧𝐢𝐜𝐚𝐥 𝐭𝐫𝐢𝐚𝐥𝐬 𝐢𝐧 𝐡𝐨𝐦𝐞𝐬 𝐚𝐧𝐝 𝐥𝐨𝐜𝐚𝐥 𝐬𝐞𝐭𝐭𝐢𝐧𝐠𝐬 𝐨𝐮𝐭𝐬𝐢𝐝𝐞 𝐨𝐟 𝐜𝐥𝐢𝐧𝐢𝐜𝐬 – 𝐚 𝐫𝐞𝐬𝐞𝐚𝐫𝐜𝐡 𝐩𝐫𝐨𝐣𝐞𝐜𝐭 𝐮𝐬𝐢𝐧𝐠 𝐢𝐧𝐭𝐞𝐫𝐯𝐢𝐞𝐰𝐬” WP CODE has recently formed a working group to translate technical/scientific documents into plain language for the general public including patients. It’s intended for those interested in learning more about decentralised clinical trials (DCT) in a more accessible and easily digestible format. The aim of this group is to foster accessibility of the Trials@Home materials, to increase awareness and educational opportunities surrounding DCTs. The group has now finished the translation of the first paper “Learning from remote decentralised clinical trial experiences: A qualitative analysis of interviews with trial personnel, patient representatives and other stakeholders” Download the translation here -> https://bit.ly/3Xz5vdz

Clinical Trials Day May 20 is an opportunity celebrate the individuals who participate in clinical trials, as well as those professionals who help run clinical research, not only doctors and scientists, but also translators that help to spread the word to the entire globe. #clinicaltrials #medicaltranslation

🔬 Discover the Most Frequent Document Types in Life Sciences Translation! We're excited to share a highlight from our recent webinar, "From Lab to Lexicon: The Crucial Role of Translation in the Life Sciences." This video dives into the most frequent document types we handle in life sciences translation and the unique challenges they present. 📄 Watch Now: https://lnkd.in/gZcA9CW5 In this video, you'll learn about: - Clinical trial protocols - Patient information leaflets - Regulatory submissions - Scientific research articles And more! Stay tuned for more insights in our upcoming video series! #LifeSciences #MedicalTranslation #Healthcare #LanguageServices #Ciklopea

The second in a three-part poster series, this scientific poster describes the mass balance and #clinical safety assessments from a human #ADME study for an oral single dose of Acoziborole. Download here: https://lnkd.in/eSd8f7Yv

PN Update: IRIS guide for applicants - How to create and submit scientific applications, for industry and individual applicants

We published our “2023 Year in Review & What’s Ahead for JAMA” yesterday. In addition to the numbers on impact & reach, we discuss: ** JAMA Express, timely publication, & new move to publish everything Online First (then in print) ** Our Top Viewed & Top Cited articles for 2023 ** JAMA’s global readership ** New focus on those early in their careers ** Thank you to peer reviewers, authors, & readers to place their trust in JAMA Check it out!